ing is superior to iron-induced T2 shortening, therefore T2*-weighted images have greater sensitivity to detect iron (9) , and are more commonly used for this purpose. It is important to be alert to detect iron overload in the liver, as it is not always clinically evident. In routine abdominal MRI protocols, in-and out-of-phase images, which are generally used for detection of fat, are also helpful in detection of iron. Iron causes signal drop on standard in-phase images, contrary to signal drop effect of fat on out-of-phase. With this principle, many iron quantification methods by MRI depends on gradient echo sequences with T2* weighting, which were acquired with progressively longer echo times.
There are two major methods in quantification of hepatic iron overload, namely, signal intensity ratio methods and relaxometry methods. Signal intensity ratio methods measure the signal intensity of the liver and another tissue or noise and give proportion of these to quantify the liver iron (10, 11) , whereas relaxometry methods measure signal intensity of the liver across multiple echo times and calculate T2 or T2* values depending on the performed sequence (12) . T2 or T2* values are inversely related with iron concentration. However, R2 or R2* values (1000/T2 or T2*) are directly related to the iron concentration and increase linearly with iron concentration determined by liver biopsy (13) . Calculation of R2* and T2* plays an important role in diagnosing the degree of iron overload for planning the treatment with iron chelating agents. A T2* value below 18 ms is accepted as hepatic iron overload (14) . A recent study demonstrated that the R2* cutoff value of 147.1 Hz (T2* value of 6.8 ms) discriminates moderate and severe hepatic iron overload from absent and mild hepatic iron overload (15) .
Magnetic field strength of the scanner is important for measuring R2 and R2* values as cardiac and liver R2* values measured on 3.0 T is higher than values measured on 1.5 T scanner (16) . Higher field strength may be an advantage in detection of tissues containing low iron and when high image resolution is needed. However, higher field strength is more sensitive to magnetic susceptibility artifact, and heavy iron overload in the tissue may cause problem in detection and quantification of iron (17) . The software for calculating R2 and R2* maps is not available on all MRI scanners. Apart from these, MRI is a good alternative to biopsy for both diagnosis and treatment monitoring of hepatic iron overload.
Hepatic iron overload
Iron homeostasis depends on the balance between daily gains (intestinal absorption, reuse from old erythrocytes) and losses (epithelial desquamation, menstruation). This balance is crucial, because there is no effective way for excretion of iron from the body (18, 19) . There are two distinct etiologic causes of iron overload; inherited or primary iron overload and secondary iron overload
Main points
• Hepatic iron overload can be diagnosed by in-and out-of-phase sequence and T2* and R2* maps.
• MRI is preferred for detection and quantification of hepatic iron.
• Knowledge of different forms of hepatic iron overload and iron sparing would allow correct diagnosis of atypical lesions in hemosiderosis.
• We describe new forms such as hypersiderosis and periportal iron sparing. syndromes. Primary iron overload (i.e., hereditary hemochromatosis) is an autosomal recessive disorder in which a defective protein causes increased intestinal absorption of iron from small intestine at 5-10 times the normal rate (20) . Secondary iron overload syndromes include iron-loading anemias (i.e., thalassemia, sideroblastic anemia, sickle cell disease, chronic hemolytic anemia, aplastic anemia, pyruvate kinase deficiency), chronic liver diseases (i.e., hepatitis C infection, nonalcoholic fatty liver disease, alcoholic fatty liver disease), and iatrogenic (i.e., red blood cell transfusion, long-term hemodialysis) and miscellaneous causes. Excess iron primarily accumulates in parenchymal cells, particularly in the liver, pancreas, heart, endocrine glands like thyroid and pituitary, and synovium in primary iron overload. However, in secondary iron overload, iron accumulates in reticuloendothelial system (spleen, Kupffer cells, bone marrow, and lymph nodes). Iron also accumulates in hepatocytes and other parenchymal cells after saturation of reticuloendothelial cells, in secondary iron overload. Detection and quantification of hepatic iron overload is important for both primary and secondary iron overload syndromes. In primary iron overload, liver iron content gives information about the risk for hepatic complications such as fibrosis and cirrhosis (4, 21, 22) . In iron-loading anemias, liver iron content provides information about total body iron (23), thus quantification of liver iron content helps to monitor these patients and the treatment (2) . Liver biopsy is the current reference standard for detection and quantification of iron overload. There are two main limitations of liver biopsy. First, the invasiveness, for which MRI is a good alternative particularly when repetitive/follow-up measurements are needed for treatment monitoring. Second, the sampling error, for which MRI might even be of benefit to determine the best location for biopsy, since hepatic iron overload can have various distributions, as illustrated in this article (4, 24, 25) . Therefore hepatic iron accumulation detection, quantification, and follow-up evaluation after treatment depend on imaging methods, especially MRI as described in the previous section.
Hepatic iron overload can be in the form of diffuse, heterogeneous, segmental, focal, hypersiderosis, intralesional siderosis, and periportal siderosis.
Diffuse siderosis
Both primary and secondary iron overload can lead to diffuse hepatic iron overload. However, diffuse siderosis is mostly observed in patients receiving multiple blood transfusions. There is a linear correlation between liver iron concentration and R2* value (1/T2*) (Fig. 1) .
Heterogeneous siderosis
Hepatic iron accumulation can be heterogeneous across the liver (26) (27) (28) (29) . However, this heterogeneity is generally not realized in visual assessment of conventional magnetic a b resonance images. In some cases, especially patients on treatment with iron chelating agents, heterogeneous siderosis can be seen on R2* maps as a treatment response (Fig. 2) .
Focal and segmental siderosis
The main distribution of iron to liver is through the portal vein. Situations like thrombosis, compression, or shunting of portal vein that decrease portal venous flow result in unequal iron deposition in different segments. Segmental siderosis was defined as segmental hypointensity on MRI and was confirmed by liver biopsy as iron deposition in previous studies (30) (31) (32) .
Focal iron accumulation can be seen in liver due to altered or absent perfusion (Fig.  3) . We observed areas of focal siderosis in patients who received chemotherapy. Focal iron deposition can be amorphous nodular in shape. These areas demonstrate focal signal drop on in-phase images compared with out-of-phase images (Fig. 4) .
Hypersiderosis
Hypersiderosis is seen as an area containing more iron compared with the rest of the liver. Theoretically, hypersiderosis can be seen in areas with third inflow due to aberrant venous drainage. Hypersiderosis appear hyperintense on R2* maps and can be seen in multiple blood transfusions (Fig. 5) .
Intralesional siderosis
Iron can accumulate in regenerative or dysplastic nodules, which are referred as "siderotic nodules" in cirrhosis, unrelated to systemic or hepatic iron overload. The detection of siderotic nodule with MRI is not challenging, however, discrimination of dysplastic nodules from regenerative nodules is not feasible (33) (Fig. 6) . Development of hepatocellular carcinoma (HCC) in a siderotic nodule has been defined as nodule-in-nodule appearance on T2-or T2*-weighted images, consisting of intermediate-high intensity focus in low-signal intensity siderotic nodule (34, 35) . Iron presence can also be shown with MRI in hemorrhagic focal liver lesions like HCCs, hepatic adenomas (36) , and some metastatic lesions like choriocarcinoma (37) and melanoma (38) .
Periportal siderosis
Excess iron due to increased intestinal absorption initially accumulates in the peri- Figure 5. a-c. In-phase (a), out-of-phase (b) , and R2* map (c) images of a patient with siderosis. A focal hypointense area in segment 4 (within the circle) shows more signal drop than rest of the liver on in-phase image compared to out-of-phase image. This area is also seen hyperintense on R2* map (within the circle), which is consistent with hypersiderosis in a siderotic liver. a b c portal hepatocytes (39) . Therefore, periportal siderosis can be observed in early phases of hepatic iron overload or after chelation treatment (Fig. 7) .
Focal hepatic iron sparing in siderotic liver
Iron sparing refers to areas of liver with less iron than surrounding parenchyma, similar to fat sparing in the liver.
Focal nodular and geographic iron sparing
Focal iron sparing can be seen in patients with hepatic iron overload due to hemosiderosis usually in segment 4. Location of focal iron sparing can match with usual areas of focal fat accumulation and focal fat sparing. Signal abnormalities in these areas most likely result from the third inflow from aberrant venous drainage into the liver. Most common aberrant venous drainage occurs from Sappey veins, right gastric vein, and left gastric vein. Focal iron sparing can be geographic or nodular in shape (Figs. 8,  9 ). Nodular forms may mimic a lesion (40) .
Tumor cells of HCCs secondary to hepatic iron overload-induced cirrhosis don't contain iron (41) . In this situation, HCC can also be detected as focal nodular iron sparing.
Periportal iron sparing
Periportal fat accumulation has been described before (39), but we could not find a case with periportal iron sparing in the literature. We observed periportal iron sparing in a patient with periportal cavernomatous transformation and hemosiderosis related to myelodysplastic syndrome (Fig. 10) . The possible mechanism of periportal sparing is normal perfusion in the vicinity of periportal space and caudate lobe. Hypertrophy of the caudate lobe supports this mechanism. Therefore, after the administration of iron chelating agent deferoxamine, iron was cleared only from the areas with normal perfusion.
Iron and fat coexistence
There can be coexisting hepatic iron overload and fat accumulation. In previous studies, it was shown that up to 40% of patients with nonalcoholic fatty liver disease have iron overload (42, 43) . On the other hand, coexistence of steatosis in patients with primary iron overload was shown to accelerate liver injury (44) . In such circumstances, in-and out-of-phase images can cause diagnostic confusion and both detection and quantification of iron and fat become difficult, especially in conventional MRI. However, quantification of both fat and iron is feasible with recent methods that calculate R2* and proton density fat fraction, simultaneously (45) . This approach can help to clarify coexistence of siderosis and steatosis and confusing patterns of fat and iron accumulation (40) (Fig. 11) .
Conclusion
There are different forms of iron accumulation and sparing in the liver, which can be a result of normal, variant, or abnormal perfusion changes. Recent MRI techniques for hepatic iron detection and quantification can enable better understanding of hepatic iron overload and iron sparing, and may prevent misdiagnosis of focal signal changes related to varying degrees of iron content in patients with siderosis. 
Different forms of iron accumulation in the liver

